• INTEGRA - Productive pipetting from 1 to 384 channels
  • We make diagnostics that matter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe, it’s free!
  • Search
  • Menu Menu
Clinical Laboratory int.

Archive for category: Featured Articles

Featured Articles

Assessment of proliferative activity in breast cancer

, 28 September 2022/in Featured Articles /by panglobal

Approaches, significance and challenges Cell proliferation is a hallmark of cancer associated with aggressiveness and response to chemotherapy. In breast cancer (BC), assessment of proliferation constitutes the main component of grading and help in management. Herein, we address the most common approaches for BC proliferation assessment, their limitations, and evolving applications to overcome these challenges.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/09/Figure-1_Updated.jpg 504 720 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-09-28 08:41:072022-09-28 08:50:35Assessment of proliferative activity in breast cancer

Conjunctival squamous intraepithelial neoplasia

, 28 September 2022/in Featured Articles /by panglobal

The in situ stage of conjunctival squamous cell carcinoma is called conjunctival squamous intraepithelial neoplasia (CSIN). The use of terms such as Bowen’s disease and ocular surface squamous neoplasia are discouraged as their meanings vary and are prone to misinterpretation. The severity of squamous epithelial dysplasia is graded by the proportion of involved surface epithelium. […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/09/Figure-1-e1664378874356.jpg 792 1000 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-09-28 08:26:432022-09-28 08:26:43Conjunctival squamous intraepithelial neoplasia
SARS-CoV-2 spike protein(Shutterstock.com)

Mass spectrometry analysis of protein glycosylation and viral infectivity

, 28 September 2022/in Featured Articles /by panglobal

The recent COVID-19 pandemic and race to develop vaccines against the causative agent, severe acute respiratory syndrome coronavirus 2, has reminded us of the important role that protein glycosylation plays in the mechanisms of pathogen infection and host immune response. CLI caught up with Dr Sanda and Dr Campos (both at Team Scientific Service Group […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/09/shutterstock_1664571382-scaled-e1664378916628.jpg 1041 1000 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-09-28 08:11:242022-09-28 08:15:36Mass spectrometry analysis of protein glycosylation and viral infectivity

Precision Microbiome Profiling: understanding the microbiome to deliver precision medicine

, 1 September 2022/in Featured Articles /by panglobal

The impact of the microbiome on a person’s health and disease is only slowly being fully realized. Here Bio-Me introduce themselves and their work to factor in the microbiome to the delivery of precision medicine.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/09/Bio-Me-Logo-white-background.png 326 801 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-09-01 12:17:142022-09-01 12:17:14Precision Microbiome Profiling: understanding the microbiome to deliver precision medicine

Secretoneurin: the next biomarker for cardiovascular disease

, 1 September 2022/in Featured Articles /by panglobal

Secretoneurin is a small neuropeptide detectable in the blood and is strong predictor for mortality in several patient cohorts with underlying cardiovascular disease. Here, CardiNor introduce themselves and their work to develop a secretoneurin test to use as part of a biomarker panel for cardiovascular disease.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/09/0I3A8328-2-scaled-e1663867872353.jpg 1067 1600 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-09-01 12:06:212022-09-01 12:06:57Secretoneurin: the next biomarker for cardiovascular disease

Microchip Imaging Cytometry set to make quantitative lab testing more economical, easy-to-use, and accessible

, 31 August 2022/in Featured Articles /by panglobal

Scientific and technical advances in the field of Microchip Imaging Cytometry (MIC) are set to advance quantitative diagnostic testing that may deliver more economical, easy-to-use, and accessible healthcare to the public, according to a new article published in Opto-Electronic Advances [1].

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/08/MIC.jpg 641 641 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-08-31 12:07:072022-08-31 12:11:51Microchip Imaging Cytometry set to make quantitative lab testing more economical, easy-to-use, and accessible

Existing drug tests can detect delta-8-THC – the latest cannabis craze

, 31 August 2022/in Featured Articles /by panglobal

As the cannabis derivative delta-8-THC grows in popularity, it’s important for drug tests to be able to detect and differentiate it from delta-9-THC – the primary psychoactive ingredient in cannabis. Breaking research showcased at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo demonstrates that common drug testing methods can do just that.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/08/cannabis-scaled.jpg 2560 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-08-31 12:00:072022-08-31 12:00:07Existing drug tests can detect delta-8-THC – the latest cannabis craze

Innovative tests may resolve challenges in children’s healthcare

, 31 August 2022/in Featured Articles /by panglobal

A first-of-its-kind test could make it easier for newborns to get care for spinal muscular atrophy, a common genetic disease that is life-threatening but treatable if caught in time. Findings on this method and a second innovative test that could improve diagnosis of paediatric urinary tract infections (UTIs) were discussed at the 2022 AACC Annual […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/08/shutterstock_2021617082-scaled-e1663868057728.jpg 800 1200 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-08-31 11:53:112022-08-31 11:53:11Innovative tests may resolve challenges in children’s healthcare

New research could reduce healthcare disparities based on race when diagnosing kidney disease

, 31 August 2022/in Featured Articles /by panglobal

New research shows that removing a race modifier from a formula used to diagnose kidney disease could lead to more equitable care for Black patients. This study and a second that examines how this same diagnostic approach impacts Asian patients was presented at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/08/shutterstock_2083276144-scaled-e1663868081985.jpg 800 1200 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-08-31 11:47:042022-08-31 11:47:51New research could reduce healthcare disparities based on race when diagnosing kidney disease

Theranos whistleblowers and experts on AI and genomic sequencing draw nearly 17,000 attendees to 2022 AACC Annual Scientific Meeting

, 31 August 2022/in Featured Articles /by panglobal

AACC welcomed thousands of medical professionals and healthcare leaders to the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo at the McCormick Place Convention Center in Chicago from July 24-28. The meeting featured ground-breaking diagnostic advances that will help solve challenging patient health problems, and affirmed just how essential laboratory medicine professionals are to […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/08/AACC-logo.jpg 218 500 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-08-31 11:41:192022-08-31 11:41:19Theranos whistleblowers and experts on AI and genomic sequencing draw nearly 17,000 attendees to 2022 AACC Annual Scientific Meeting
Page 3 of 134‹12345›»
Forum Labo Paris March 2023

Latest issue of Clinical laboratory

December 2022 / January 2023

27 January 2023

DiaSys Procalcitonin FS is a fluid-stable, particle enhanced immunoturbidimetric assay, applicable on various clinical chemistry analyzers.

26 January 2023

Tetra Pharm Technologies secures €9 million in Series A Round to expand R&D Operations

26 January 2023

Watchmaker Genomics is proud to announce that its Quality Management System has achieved ISO 13485:2016 certification.

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release

Hastelweg 250
5652 CN Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only